As of 2025-09-11, the Intrinsic Value of Tenaya Therapeutics Inc (TNYA) is -3.06 USD. This TNYA valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.30 USD, the upside of Tenaya Therapeutics Inc is -335.09%.
Based on its market price of 1.30 USD and our intrinsic valuation, Tenaya Therapeutics Inc (TNYA) is overvalued by 335.09%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -3.06 - -3.06 | -3.06 | -335.09% |
| P/E | (10.10) - (12.71) | (12.10) | -1030.9% |
| DDM - Stable | (5.54) - (23.05) | (14.29) | -1199.6% |
| DDM - Multi | (0.10) - (0.31) | (0.15) | -111.6% |
| Market Cap (mil) | 211.87 |
| Beta | 3.24 |
| Outstanding shares (mil) | 162.98 |
| Enterprise Value (mil) | 149.20 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.05% |
| Cost of Debt | 5.00% |
| WACC | 6.36% |